- Tytuł:
- Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
- Autorzy:
- Źródło:
- In eClinicalMedicine August 2023 62
Czasopismo naukowe